Global Tumor Biomarker Test Market Insights and Forecast to 2031

Report ID: 1564664 | Published Date: Nov 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tumor Biomarker Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Prostate Specific Antigen Tests
        1.2.3 CTC Tests
        1.2.4 Alpha-Fetoprotein (AFP) Tests
        1.2.5 CA Test
        1.2.6 HER2 Tests
        1.2.7 BRCA Test
        1.2.8 Anaplastic Lymphoma Kinase (ALK) Tests
        1.2.9 EGFR Mutation Tests
        1.2.10 KRAS Test
        1.2.11 Others
    1.3 Market by Application
        1.3.1 Global Tumor Biomarker Test Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Lung cancer
        1.3.3 Breast cancer
        1.3.4 Colorectal
        1.3.5 Prostate Cancer
        1.3.6 Blood Cancer
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Tumor Biomarker Test Market Perspective (2017-2028)
    2.2 Tumor Biomarker Test Growth Trends by Region
        2.2.1 Tumor Biomarker Test Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Tumor Biomarker Test Historic Market Size by Region (2017-2022)
        2.2.3 Tumor Biomarker Test Forecasted Market Size by Region (2023-2028)
    2.3 Tumor Biomarker Test Market Dynamics
        2.3.1 Tumor Biomarker Test Industry Trends
        2.3.2 Tumor Biomarker Test Market Drivers
        2.3.3 Tumor Biomarker Test Market Challenges
        2.3.4 Tumor Biomarker Test Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Tumor Biomarker Test Players by Revenue
        3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2017-2022)
        3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2017-2022)
    3.2 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Tumor Biomarker Test Revenue
    3.4 Global Tumor Biomarker Test Market Concentration Ratio
        3.4.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2021
    3.5 Tumor Biomarker Test Key Players Head office and Area Served
    3.6 Key Players Tumor Biomarker Test Product Solution and Service
    3.7 Date of Enter into Tumor Biomarker Test Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Biomarker Test Breakdown Data by Type
    4.1 Global Tumor Biomarker Test Historic Market Size by Type (2017-2022)
    4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2023-2028)
5 Tumor Biomarker Test Breakdown Data by Application
    5.1 Global Tumor Biomarker Test Historic Market Size by Application (2017-2022)
    5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Tumor Biomarker Test Market Size (2017-2028)
    6.2 North America Tumor Biomarker Test Market Size by Type
        6.2.1 North America Tumor Biomarker Test Market Size by Type (2017-2022)
        6.2.2 North America Tumor Biomarker Test Market Size by Type (2023-2028)
        6.2.3 North America Tumor Biomarker Test Market Share by Type (2017-2028)
    6.3 North America Tumor Biomarker Test Market Size by Application
        6.3.1 North America Tumor Biomarker Test Market Size by Application (2017-2022)
        6.3.2 North America Tumor Biomarker Test Market Size by Application (2023-2028)
        6.3.3 North America Tumor Biomarker Test Market Share by Application (2017-2028)
    6.4 North America Tumor Biomarker Test Market Size by Country
        6.4.1 North America Tumor Biomarker Test Market Size by Country (2017-2022)
        6.4.2 North America Tumor Biomarker Test Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Tumor Biomarker Test Market Size (2017-2028)
    7.2 Europe Tumor Biomarker Test Market Size by Type
        7.2.1 Europe Tumor Biomarker Test Market Size by Type (2017-2022)
        7.2.2 Europe Tumor Biomarker Test Market Size by Type (2023-2028)
        7.2.3 Europe Tumor Biomarker Test Market Share by Type (2017-2028)
    7.3 Europe Tumor Biomarker Test Market Size by Application
        7.3.1 Europe Tumor Biomarker Test Market Size by Application (2017-2022)
        7.3.2 Europe Tumor Biomarker Test Market Size by Application (2023-2028)
        7.3.3 Europe Tumor Biomarker Test Market Share by Application (2017-2028)
    7.4 Europe Tumor Biomarker Test Market Size by Country
        7.4.1 Europe Tumor Biomarker Test Market Size by Country (2017-2022)
        7.4.2 Europe Tumor Biomarker Test Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Tumor Biomarker Test Market Size (2017-2028)
    8.2 Asia-Pacific Tumor Biomarker Test Market Size by Type
        8.2.1 Asia-Pacific Tumor Biomarker Test Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Tumor Biomarker Test Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Tumor Biomarker Test Market Share by Type (2017-2028)
    8.3 Asia-Pacific Tumor Biomarker Test Market Size by Application
        8.3.1 Asia-Pacific Tumor Biomarker Test Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Tumor Biomarker Test Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Tumor Biomarker Test Market Share by Application (2017-2028)
    8.4 Asia-Pacific Tumor Biomarker Test Market Size by Region
        8.4.1 Asia-Pacific Tumor Biomarker Test Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Tumor Biomarker Test Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Tumor Biomarker Test Market Size (2017-2028)
    9.2 Latin America Tumor Biomarker Test Market Size by Type
        9.2.1 Latin America Tumor Biomarker Test Market Size by Type (2017-2022)
        9.2.2 Latin America Tumor Biomarker Test Market Size by Type (2023-2028)
        9.2.3 Latin America Tumor Biomarker Test Market Share by Type (2017-2028)
    9.3 Latin America Tumor Biomarker Test Market Size by Application
        9.3.1 Latin America Tumor Biomarker Test Market Size by Application (2017-2022)
        9.3.2 Latin America Tumor Biomarker Test Market Size by Application (2023-2028)
        9.3.3 Latin America Tumor Biomarker Test Market Share by Application (2017-2028)
    9.4 Latin America Tumor Biomarker Test Market Size by Country
        9.4.1 Latin America Tumor Biomarker Test Market Size by Country (2017-2022)
        9.4.2 Latin America Tumor Biomarker Test Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Tumor Biomarker Test Market Size (2017-2028)
    10.2 Middle East & Africa Tumor Biomarker Test Market Size by Type
        10.2.1 Middle East & Africa Tumor Biomarker Test Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Tumor Biomarker Test Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Tumor Biomarker Test Market Share by Type (2017-2028)
    10.3 Middle East & Africa Tumor Biomarker Test Market Size by Application
        10.3.1 Middle East & Africa Tumor Biomarker Test Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Tumor Biomarker Test Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Tumor Biomarker Test Market Share by Application (2017-2028)
    10.4 Middle East & Africa Tumor Biomarker Test Market Size by Country
        10.4.1 Middle East & Africa Tumor Biomarker Test Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Tumor Biomarker Test Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories, Inc.
        11.1.1 Abbott Laboratories, Inc. Company Details
        11.1.2 Abbott Laboratories, Inc. Business Overview
        11.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction
        11.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.1.5 Abbott Laboratories, Inc. Recent Developments
    11.2 Agilent Technologies
        11.2.1 Agilent Technologies Company Details
        11.2.2 Agilent Technologies Business Overview
        11.2.3 Agilent Technologies Tumor Biomarker Test Introduction
        11.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2017-2022)
        11.2.5 Agilent Technologies Recent Developments
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Details
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Tumor Biomarker Test Introduction
        11.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2017-2022)
        11.3.5 AstraZeneca Recent Developments
    11.4 Becton Dickinson & Co.
        11.4.1 Becton Dickinson & Co. Company Details
        11.4.2 Becton Dickinson & Co. Business Overview
        11.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction
        11.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.4.5 Becton Dickinson & Co. Recent Developments
    11.5 Biocept Inc.
        11.5.1 Biocept Inc. Company Details
        11.5.2 Biocept Inc. Business Overview
        11.5.3 Biocept Inc. Tumor Biomarker Test Introduction
        11.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.5.5 Biocept Inc. Recent Developments
    11.6 Cancer Genetics Inc.
        11.6.1 Cancer Genetics Inc. Company Details
        11.6.2 Cancer Genetics Inc. Business Overview
        11.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction
        11.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.6.5 Cancer Genetics Inc. Recent Developments
    11.7 Danaher Corporation
        11.7.1 Danaher Corporation Company Details
        11.7.2 Danaher Corporation Business Overview
        11.7.3 Danaher Corporation Tumor Biomarker Test Introduction
        11.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2017-2022)
        11.7.5 Danaher Corporation Recent Developments
    11.8 Foundation Medicine Inc.
        11.8.1 Foundation Medicine Inc. Company Details
        11.8.2 Foundation Medicine Inc. Business Overview
        11.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction
        11.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.8.5 Foundation Medicine Inc. Recent Developments
    11.9 Illumina Inc.
        11.9.1 Illumina Inc. Company Details
        11.9.2 Illumina Inc. Business Overview
        11.9.3 Illumina Inc. Tumor Biomarker Test Introduction
        11.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.9.5 Illumina Inc. Recent Developments
    11.10 LabCorp Of America Holdings
        11.10.1 LabCorp Of America Holdings Company Details
        11.10.2 LabCorp Of America Holdings Business Overview
        11.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction
        11.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2017-2022)
        11.10.5 LabCorp Of America Holdings Recent Developments
    11.11 Luminex Corporation
        11.11.1 Luminex Corporation Company Details
        11.11.2 Luminex Corporation Business Overview
        11.11.3 Luminex Corporation Tumor Biomarker Test Introduction
        11.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2017-2022)
        11.11.5 Luminex Corporation Recent Developments
    11.12 Myriad Genetics Inc.
        11.12.1 Myriad Genetics Inc. Company Details
        11.12.2 Myriad Genetics Inc. Business Overview
        11.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction
        11.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.12.5 Myriad Genetics Inc. Recent Developments
    11.13 NanoString Technologies Inc.
        11.13.1 NanoString Technologies Inc. Company Details
        11.13.2 NanoString Technologies Inc. Business Overview
        11.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction
        11.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2017-2022)
        11.13.5 NanoString Technologies Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Prostate Specific Antigen Tests
    Table 3. Key Players of CTC Tests
    Table 4. Key Players of Alpha-Fetoprotein (AFP) Tests
    Table 5. Key Players of CA Test
    Table 6. Key Players of HER2 Tests
    Table 7. Key Players of BRCA Test
    Table 8. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests
    Table 9. Key Players of EGFR Mutation Tests
    Table 10. Key Players of KRAS Test
    Table 11. Key Players of Others
    Table 12. Global Tumor Biomarker Test Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 13. Global Tumor Biomarker Test Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 14. Global Tumor Biomarker Test Market Size by Region (2017-2022) & (US$ Million)
    Table 15. Global Tumor Biomarker Test Market Share by Region (2017-2022)
    Table 16. Global Tumor Biomarker Test Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 17. Global Tumor Biomarker Test Market Share by Region (2023-2028)
    Table 18. Tumor Biomarker Test Market Trends
    Table 19. Tumor Biomarker Test Market Drivers
    Table 20. Tumor Biomarker Test Market Challenges
    Table 21. Tumor Biomarker Test Market Restraints
    Table 22. Global Tumor Biomarker Test Revenue by Players (2017-2022) & (US$ Million)
    Table 23. Global Tumor Biomarker Test Revenue Share by Players (2017-2022)
    Table 24. Global Top Tumor Biomarker Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2021)
    Table 25. Ranking of Global Top Tumor Biomarker Test Companies by Revenue (US$ Million) in 2021
    Table 26. Global 5 Largest Players Market Share by Tumor Biomarker Test Revenue (CR5 and HHI) & (2017-2022)
    Table 27. Key Players Headquarters and Area Served
    Table 28. Key Players Tumor Biomarker Test Product Solution and Service
    Table 29. Date of Enter into Tumor Biomarker Test Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Tumor Biomarker Test Market Size by Type (2017-2022) & (US$ Million)
    Table 32. Global Tumor Biomarker Test Revenue Market Share by Type (2017-2022)
    Table 33. Global Tumor Biomarker Test Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 34. Global Tumor Biomarker Test Revenue Market Share by Type (2023-2028)
    Table 35. Global Tumor Biomarker Test Market Size by Application (2017-2022) & (US$ Million)
    Table 36. Global Tumor Biomarker Test Revenue Share by Application (2017-2022)
    Table 37. Global Tumor Biomarker Test Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 38. Global Tumor Biomarker Test Revenue Share by Application (2023-2028)
    Table 39. North America Tumor Biomarker Test Market Size by Type (2017-2022) & (US$ Million)
    Table 40. North America Tumor Biomarker Test Market Size by Type (2023-2028) & (US$ Million)
    Table 41. North America Tumor Biomarker Test Market Size by Application (2017-2022) & (US$ Million)
    Table 42. North America Tumor Biomarker Test Market Size by Application (2023-2028) & (US$ Million)
    Table 43. North America Tumor Biomarker Test Market Size by Country (2017-2022) & (US$ Million)
    Table 44. North America Tumor Biomarker Test Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Europe Tumor Biomarker Test Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Europe Tumor Biomarker Test Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Europe Tumor Biomarker Test Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Europe Tumor Biomarker Test Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Europe Tumor Biomarker Test Market Size by Country (2017-2022) & (US$ Million)
    Table 50. Europe Tumor Biomarker Test Market Size by Country (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Tumor Biomarker Test Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Tumor Biomarker Test Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Tumor Biomarker Test Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Tumor Biomarker Test Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Asia Pacific Tumor Biomarker Test Market Size by Region (2017-2022) & (US$ Million)
    Table 56. Asia Pacific Tumor Biomarker Test Market Size by Region (2023-2028) & (US$ Million)
    Table 57. Latin America Tumor Biomarker Test Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Latin America Tumor Biomarker Test Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Latin America Tumor Biomarker Test Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Latin America Tumor Biomarker Test Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Latin America Tumor Biomarker Test Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Latin America Tumor Biomarker Test Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Tumor Biomarker Test Market Size by Type (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Tumor Biomarker Test Market Size by Type (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Tumor Biomarker Test Market Size by Application (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Tumor Biomarker Test Market Size by Application (2023-2028) & (US$ Million)
    Table 67. Middle East and Africa Tumor Biomarker Test Market Size by Country (2017-2022) & (US$ Million)
    Table 68. Middle East and Africa Tumor Biomarker Test Market Size by Country (2023-2028) & (US$ Million)
    Table 69. Abbott Laboratories, Inc. Company Details
    Table 70. Abbott Laboratories, Inc. Business Overview
    Table 71. Abbott Laboratories, Inc. Tumor Biomarker Test Product
    Table 72. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 73. Abbott Laboratories, Inc. Recent Developments
    Table 74. Agilent Technologies Company Details
    Table 75. Agilent Technologies Business Overview
    Table 76. Agilent Technologies Tumor Biomarker Test Product
    Table 77. Agilent Technologies Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 78. Agilent Technologies Recent Developments
    Table 79. AstraZeneca Company Details
    Table 80. AstraZeneca Business Overview
    Table 81. AstraZeneca Tumor Biomarker Test Product
    Table 82. AstraZeneca Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 83. AstraZeneca Recent Developments
    Table 84. Becton Dickinson & Co. Company Details
    Table 85. Becton Dickinson & Co. Business Overview
    Table 86. Becton Dickinson & Co. Tumor Biomarker Test Product
    Table 87. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 88. Becton Dickinson & Co. Recent Developments
    Table 89. Biocept Inc. Company Details
    Table 90. Biocept Inc. Business Overview
    Table 91. Biocept Inc. Tumor Biomarker Test Product
    Table 92. Biocept Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 93. Biocept Inc. Recent Developments
    Table 94. Cancer Genetics Inc. Company Details
    Table 95. Cancer Genetics Inc. Business Overview
    Table 96. Cancer Genetics Inc. Tumor Biomarker Test Product
    Table 97. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 98. Cancer Genetics Inc. Recent Developments
    Table 99. Danaher Corporation Company Details
    Table 100. Danaher Corporation Business Overview
    Table 101. Danaher Corporation Tumor Biomarker Test Product
    Table 102. Danaher Corporation Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 103. Danaher Corporation Recent Developments
    Table 104. Foundation Medicine Inc. Company Details
    Table 105. Foundation Medicine Inc. Business Overview
    Table 106. Foundation Medicine Inc. Tumor Biomarker Test Product
    Table 107. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 108. Foundation Medicine Inc. Recent Developments
    Table 109. Illumina Inc. Company Details
    Table 110. Illumina Inc. Business Overview
    Table 111. Illumina Inc. Tumor Biomarker Test Product
    Table 112. Illumina Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 113. Illumina Inc. Recent Developments
    Table 114. LabCorp Of America Holdings Company Details
    Table 115. LabCorp Of America Holdings Business Overview
    Table 116. LabCorp Of America Holdings Tumor Biomarker Test Product
    Table 117. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 118. LabCorp Of America Holdings Recent Developments
    Table 119. Luminex Corporation Company Details
    Table 120. Luminex Corporation Business Overview
    Table 121. Luminex Corporation Tumor Biomarker Test Product
    Table 122. Luminex Corporation Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 123. Luminex Corporation Recent Developments
    Table 124. Myriad Genetics Inc. Company Details
    Table 125. Myriad Genetics Inc. Business Overview
    Table 126. Myriad Genetics Inc. Tumor Biomarker Test Product
    Table 127. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 128. Myriad Genetics Inc. Recent Developments
    Table 129. NanoString Technologies Inc. Company Details
    Table 130. NanoString Technologies Inc. Business Overview
    Table 131. NanoString Technologies Inc. Tumor Biomarker Test Product
    Table 132. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2017-2022) & (US$ Million)
    Table 133. NanoString Technologies Inc. Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tumor Biomarker Test Market Share by Type: 2021 VS 2028
    Figure 2. Prostate Specific Antigen Tests Features
    Figure 3. CTC Tests Features
    Figure 4. Alpha-Fetoprotein (AFP) Tests Features
    Figure 5. CA Test Features
    Figure 6. HER2 Tests Features
    Figure 7. BRCA Test Features
    Figure 8. Anaplastic Lymphoma Kinase (ALK) Tests Features
    Figure 9. EGFR Mutation Tests Features
    Figure 10. KRAS Test Features
    Figure 11. Others Features
    Figure 12. Global Tumor Biomarker Test Market Share by Application: 2021 VS 2028
    Figure 13. Lung cancer Case Studies
    Figure 14. Breast cancer Case Studies
    Figure 15. Colorectal Case Studies
    Figure 16. Prostate Cancer Case Studies
    Figure 17. Blood Cancer Case Studies
    Figure 18. Tumor Biomarker Test Report Years Considered
    Figure 19. Global Tumor Biomarker Test Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 20. Global Tumor Biomarker Test Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 21. Global Tumor Biomarker Test Market Share by Region: 2021 VS 2028
    Figure 22. Global Tumor Biomarker Test Market Share by Players in 2021
    Figure 23. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2021)
    Figure 24. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2021
    Figure 25. North America Tumor Biomarker Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. North America Tumor Biomarker Test Market Size Market Share by Type (2017-2028)
    Figure 27. North America Tumor Biomarker Test Market Size Market Share by Application (2017-2028)
    Figure 28. North America Tumor Biomarker Test Market Size Share by Country (2017-2028)
    Figure 29. United States Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Canada Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Europe Tumor Biomarker Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Europe Tumor Biomarker Test Market Size Market Share by Type (2017-2028)
    Figure 33. Europe Tumor Biomarker Test Market Size Market Share by Application (2017-2028)
    Figure 34. Europe Tumor Biomarker Test Market Size Share by Country (2017-2028)
    Figure 35. Germany Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. France Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. U.K. Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Italy Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Russia Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Nordic Countries Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Asia-Pacific Tumor Biomarker Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Asia Pacific Tumor Biomarker Test Market Size Market Share by Type (2017-2028)
    Figure 43. Asia Pacific Tumor Biomarker Test Market Size Market Share by Application (2017-2028)
    Figure 44. Asia Pacific Tumor Biomarker Test Market Size Share by Region (2017-2028)
    Figure 45. China Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Japan Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. South Korea Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. India Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Australia Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 51. Latin America Tumor Biomarker Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Latin America Tumor Biomarker Test Market Size Market Share by Type (2017-2028)
    Figure 53. Latin America Tumor Biomarker Test Market Size Market Share by Application (2017-2028)
    Figure 54. Latin America Tumor Biomarker Test Market Size Share by Country (2017-2028)
    Figure 55. Mexico Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Brazil Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Middle East & Africa Tumor Biomarker Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 58. Middle East and Africa Tumor Biomarker Test Market Size Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa Tumor Biomarker Test Market Size Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa Tumor Biomarker Test Market Size Share by Country (2017-2028)
    Figure 61. Turkey Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 63. UAE Tumor Biomarker Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 64. Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 65. Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 66. AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 67. Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 68. Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 69. Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 70. Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 71. Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 72. Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 73. LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 74. Luminex Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 75. Myriad Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 76. NanoString Technologies Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Frequently Asked Questions
Tumor Biomarker Test report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tumor Biomarker Test report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tumor Biomarker Test report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports